<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Oncología > Inmunoterapia > DA - CIMA - Oncología - Inmunoterapia - Artículos de Revista >

Role of anti-idiotype vaccines in the modern treatment of human follicular lymphoma
Autor(es) : Bendandi, M. (Maurizio)
Palabras clave : Antibodies, Anti-Idiotypic/therapeutic use
Cancer Vaccines/therapeutic use
Lymphoma, Follicular/therapy
Fecha incorporación: 2001
Editorial : Expert Reviews
Versión del editor: http://www.expert-reviews.com/doi/abs/10.1586/14737140.1.1.65
ISSN: 1744-8328
Cita: Bendandi M. Role of anti-idiotype vaccines in the modern treatment of human follicular lymphoma. Expert Rev Anticancer Ther 2001 Jun;1(1):65-72.
Abstract Cancer vaccines are currently conceived as therapeutic tools, in contrast to the prophylactic vaccines that have resolved the problem of a number of infectious diseases. Among the former, anti-idiotype vaccines for human follicular lymphoma have begun to produce tangible clinical results. Just 10 years ago it was not even known whether patients could be immunized against their own tumor antigens and now as many as two independent Phase III clinical trials based on this finding are underway. The rapidity of this development encourages the hope that active immunotherapy may soon become decisive in oncology. For the time being, many important results have already been achieved: the evidence of vaccine-induced, tumor-specific humoral/cellular responses and the first documented molecular remissions following vaccination.
Enlace permanente: http://hdl.handle.net/10171/19952
Aparece en las colecciones: DA - CIMA - Oncología - Inmunoterapia - Artículos de Revista
DA - CUN - Hematología y Hemoterapia - Artículos de revista
DA - CUN - Área de Terapia Celular - Artículos de revista
DA - Medicina - Hematología - Artículos de revista

Ficheros en este registro:

No hay ficheros asociados a este ítem.

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.